PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

NCT04129931 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

950

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: MCT
DRUG: Clazakizumab
DRUG: Broncho-Vaxom
DRUG: Imatinib Mesylate
DRUG: Cavosonstat
OTHER: Placebo

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]